Published in Virology on April 01, 1995
The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature (2009) 5.06
Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature (2009) 4.49
A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J Virol (2002) 3.37
The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J (2001) 2.52
PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J Virol (2001) 1.98
Definition of the minimal viral components required for the initiation of unprimed RNA synthesis by influenza virus RNA polymerase. Nucleic Acids Res (2002) 1.98
Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res (1996) 1.89
Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification. J Virol (2000) 1.86
The amino-terminal one-third of the influenza virus PA protein is responsible for the induction of proteolysis. J Virol (1996) 1.79
Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc Natl Acad Sci U S A (2010) 1.77
The influenza A virus PB2 polymerase subunit is required for the replication of viral RNA. J Virol (1997) 1.71
Structural basis of the influenza A virus RNA polymerase PB2 RNA-binding domain containing the pathogenicity-determinant lysine 627 residue. J Biol Chem (2009) 1.70
The replication activity of influenza virus polymerase is linked to the capacity of the PA subunit to induce proteolysis. J Virol (2000) 1.69
Temperature-sensitive lesions in two influenza A viruses defective for replicative transcription disrupt RNA binding by the nucleoprotein. J Virol (1999) 1.65
Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors. Antimicrob Agents Chemother (1996) 1.58
Characterization of influenza virus PB1 protein binding to viral RNA: two separate regions of the protein contribute to the interaction domain. J Virol (1999) 1.52
Threonine 157 of influenza virus PA polymerase subunit modulates RNA replication in infectious viruses. J Virol (2003) 1.50
Mutational analysis identifies functional domains in the influenza A virus PB2 polymerase subunit. J Virol (1996) 1.38
Mutagenic analysis of the 5' arm of the influenza A virus virion RNA promoter defines the sequence requirements for endonuclease activity. J Virol (2001) 1.35
A novel antiviral agent which inhibits the endonuclease of influenza viruses. Antimicrob Agents Chemother (1996) 1.31
Hairpin loop structure in the 3' arm of the influenza A virus virion RNA promoter is required for endonuclease activity. J Virol (2001) 1.23
Endonuclease substrate selectivity characterized with full-length PA of influenza A virus polymerase. Virology (2012) 1.07
Innate immune restriction and antagonism of viral RNA lacking 2׳-O methylation. Virology (2015) 0.95
Genetically engineered live attenuated influenza A virus vaccine candidates. J Virol (1997) 0.95
In vitro polymerase activity of Thogoto virus: evidence for a unique cap-snatching mechanism in a tick-borne orthomyxovirus. J Virol (1997) 0.95
Influenza A virus RNA-dependent RNA polymerase: analysis of RNA synthesis in vitro. J Virol (1996) 0.87
Deep sequencing reveals the eight facets of the influenza A/HongKong/1/1968 (H3N2) virus cap-snatching process. Sci Rep (2014) 0.86
The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design. Med Res Rev (2016) 0.80
Crystallization and X-ray diffraction analysis of the RNA primer/promoter-binding domain of influenza A virus RNA-dependent RNA polymerase PB2. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.79
Influenza A virus preferentially snatches noncoding RNA caps. RNA (2015) 0.79
Photodynamic therapy. J Natl Cancer Inst (1998) 12.83
Evidence for virus-specific noncapsid proteins in poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A (1965) 11.84
Evidence for large precursor proteins in poliovirus synthesis. Proc Natl Acad Sci U S A (1968) 8.24
Classification of rhabdovirus proteins: a proposal. J Virol (1972) 5.54
Protein synthesis in vesicular stomatitis virus-infected HeLa cells. Virology (1970) 5.14
Polysomal ribonucleic acid of vesicular stomatitis virus-infected HeLa cells. Virology (1970) 4.85
Plus and minus strand leader RNAs in negative strand virus-infected cells. Cell (1979) 3.50
The decrease in size and synthetic activity of poliovirus polysomes late in the infectious cycle. Virology (1967) 3.41
Eradication of posterior capsule opacification: documentation of a marked decrease in Nd:YAG laser posterior capsulotomy rates noted in an analysis of 5416 pseudophakic human eyes obtained postmortem. Ophthalmology (2001) 3.05
Determination of the gene sequence of poliovirus with pactamycin. Proc Natl Acad Sci U S A (1971) 2.80
OpenPET: A Flexible Electronics System for Radiotracer Imaging. IEEE Trans Nucl Sci (2009) 2.64
In vitro assembly of poliovirus-related particles. Virology (1968) 2.55
Partial structural analysis of the oligosaccharide moieties of the vesicular stomatitis virus glycoprotein by sequential chemical and enzymatic degradation. Virology (1977) 2.36
Specific changes in the oligosaccharide moieties of VSV grown in different lectin-resistnat CHO cells. Cell (1978) 2.30
Oligosaccharide chains are trimmed during synthesis of the envelope glycoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1978) 2.29
Purification and properties of HeLa cell plasma membranes. J Biol Chem (1971) 2.29
Soluble RNA polymerase complex from poliovirus-infected HeLa cells. Virology (1970) 2.26
Evidence for differences in size and composition of the poliovirus-specific polypeptides in infected HeLa cells. Virology (1968) 2.23
Characterization of ribonuclease-resistant RNA from poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A (1965) 2.22
Interactions of vesicular stomatitis virus structural proteins with HeLa plasma membranes. Nat New Biol (1971) 2.19
Assembly of vesicular stomatitis virus glycoprotein and matrix protein into HeLa cell plasma membranes. J Mol Biol (1976) 2.10
Phosphorylation of vesicular stomatitis virus in vivo and in vitro. J Virol (1974) 2.07
Glycosylation of vesicular stomatitis virus glycoprotein in virus-infected HeLa cells. J Virol (1976) 2.06
Inhibition of cleavage of large poliovirus-specific precursor proteins in infected HeLa cells by inhibitors of proteolytic enzymes. J Virol (1972) 2.06
Adenylate-rich sequences in vesicular stomatitis virus messenger ribonucleic acid. J Virol (1972) 2.05
Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in alpha beta(+) T cells. Nature (1994) 1.94
Evidence for ambiguity in the posttranslational cleavage of poliovirus proteins. Virology (1970) 1.93
In vitro synthesis of proteins by membrane-bound polyribosomes from vesicular stomatitis virus-infected HeLa cells. J Virol (1974) 1.90
Scedosporium prolificans keratouveitis in association with a contact lens retained intraocularly over a long term. J Clin Microbiol (2001) 1.84
In vitro protein synthetic activity of membrane-bound poliovirus polyribosomes. Virology (1971) 1.84
Silicone oil adhesion to intraocular lenses: an experimental study comparing various biomaterials. J Cataract Refract Surg (1997) 1.67
Constitution and function of polyribosomes of poliovirus-infected HeLa cells. Virology (1965) 1.65
Association of vesicular stomatitis virus proteins with HeLa cell membranes and released virus. J Virol (1976) 1.57
The 5'-terminal nucleotides of hepatitis A virus RNA, but not poliovirus RNA, are required for infectivity. J Virol (1991) 1.55
Preparative elution of proteins blotted to Immobilon membranes. Anal Biochem (1988) 1.53
Identification of terminal adenylyl transferase activity of the poliovirus polymerase 3Dpol. J Virol (1994) 1.52
Elimination of cataract blindness: a global perspective entering the new millenium. Surv Ophthalmol (2000) 1.52
Glycosylation sites of vesicular stomatitis virus glycoprotein. J Virol (1976) 1.50
Identification of the hepatitis A virus internal ribosome entry site: in vivo and in vitro analysis of bicistronic RNAs containing the HAV 5' noncoding region. Virology (1993) 1.47
Vesicular stomatitis virus envelope glycoprotein alterations induced by host cell transformation. Cell (1974) 1.45
Maturation pathway for ribosomal RNA in the Hela cell nucleolus. Nat New Biol (1972) 1.44
Germinal center formation, immunoglobulin class switching, and autoantibody production driven by "non alpha/beta" T cells. J Exp Med (1996) 1.42
Pathological examination of an explanted phakic posterior chamber intraocular lens. J Cataract Refract Surg (1999) 1.40
Oligosaccharide moieties of the glycoprotein of vesicular stomatitis virus. J Virol (1976) 1.40
Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine. J Immunol (1997) 1.38
In vitro protein-synthesizing activity of vesicular stomatitis virus-infected cell extracts. J Virol (1973) 1.37
Effect of vesicular stomatitis virus infection on the histocompatibility antigen of L cells. J Virol (1972) 1.36
Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res (1997) 1.36
Interactions of vesicular stomatitis virus with murine cell surface antigens. J Virol (1976) 1.35
Purification, thioredoxin renaturation, and reconstituted activity of the three subunits of the influenza A virus RNA polymerase. Proc Natl Acad Sci U S A (1988) 1.30
RNA synthesis of vesicular stomatitis virus-infected cells: in vivo regulation of replication. J Virol (1979) 1.29
Stimulation of vesicular stomatitis virus in vitro RNA synthesis by microtubule-associated proteins. Proc Natl Acad Sci U S A (1986) 1.26
Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4. Virology (1993) 1.22
Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. J Immunol (1996) 1.21
In vitro association of vesicular stomatitis virus proteins with purified HeLa and erythrocyte plasma membranes. Virology (1974) 1.20
Identification of a trans-acting activity from liver that stimulates hepatitis A virus translation in vitro. Virology (1993) 1.20
In vitro replication and assembly of vesicular stomatitis virus nucleocapsids. Virology (1981) 1.19
Hepatitis A virus polyprotein synthesis initiates from two alternative AUG codons. Virology (1992) 1.19
Measurement of the negative muon anomalous magnetic moment to 0.7 ppm. Phys Rev Lett (2004) 1.19
Surgical prevention of posterior capsule opacification. Part 1: Progress in eliminating this complication of cataract surgery. J Cataract Refract Surg (2000) 1.19
Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol (1987) 1.17
Disaggregation of HeLa cell polysomes after infection with poliovirus. Virology (1967) 1.16
Proteolytic activity of hepatitis A virus 3C protein. J Virol (1991) 1.15
Hepatitis A virus capsid protein VP1 has a heterogeneous C terminus. J Virol (1999) 1.15
Polyprotein processing in cis and in trans by hepatitis A virus 3C protease cloned and expressed in Escherichia coli. J Virol (1992) 1.14
Purification of oncornaviruses by agglutination with concanacalin A (murine leukemia virus-phytohemagglutinin-friend virus). Proc Natl Acad Sci U S A (1973) 1.13
Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. Cancer Epidemiol Biomarkers Prev (1998) 1.12
Characterization of the phosphorylated small enzyme subunit, NS, of the vesicular stomatitis virus RNA polymerase. J Biol Chem (1984) 1.11
Comparison of polysomal structures of uninfected and poliovirus infected HeLa cells. Virology (1971) 1.11
Characterization of vesicular stomatitis virus replicating complexes isolated in renografin gradients. Virology (1979) 1.10
Replication and assembly of VSV nucleocapsids: protein association with RNPs and the effects of cycloheximide on replication. Virology (1980) 1.09
Primary cleavage of the HAV capsid protein precursor in the middle of the proposed 2A coding region. Virology (1993) 1.09
Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population. Clin Exp Allergy (2003) 1.09
Restricted replication of vesicular stomatitis virus in human lymphoblastoid cells. J Virol (1973) 1.08
A minor microtubule-associated protein is responsible for the stimulation of vesicular stomatitis virus transcription in vitro. J Gen Virol (1990) 1.08
Relationship between virion-associated kinase-effected phosphorylation and transcription activity of vesicular stomatitis virus. Virology (1980) 1.08
Rhabdoviridae. Report of the Rhabdovirus Study Group, International Committee on Taxonomy of Viruses. Intervirology (1979) 1.07
Oligosaccharide chains of avian RNA tumor virus glycoproteins contain heterogeneous oligomannosyl cores. J Virol (1979) 1.06
Influenza A virus in vitro transcription: roles of NS1 and NP proteins in regulating RNA synthesis. Virology (1991) 1.05
Interlenticular opacification: clinicopathological correlation of a complication of posterior chamber piggyback intraocular lenses. J Cataract Refract Surg (2000) 1.04
Detection of hepatitis A virus RNA and capsid antigen in individual cells. Virus Res (1989) 1.04
Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues. Cancer Lett (1997) 1.01
Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. Clin Exp Allergy (2003) 1.01
Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light. Br J Cancer (1999) 1.01
Replication of hepatitis A viruses with chimeric 5' nontranslated regions. J Virol (1996) 0.99
SDS-acrylamide gel electrophoresis and its application to the proteins of poliovirus- and adenovirus-infected human cells. J Cell Physiol (1970) 0.99
trans-encapsidation of a poliovirus replicon by different picornavirus capsid proteins. J Virol (1998) 0.99
Further characterization of the replicative complex of vesicular stomatitis virus. J Virol (1979) 0.98
Expression of hepatitis A virus precursor protein P3 in vivo and in vitro: polyprotein processing of the 3CD cleavage site. Virology (1994) 0.98
Anterior capsule opacification: a histopathological study comparing different IOL styles. Ophthalmology (2000) 0.96
Synthesis of VSV RNPs in vitro by cellular VSV RNPs added to uninfected HeLa cell extracts: VSV protein requirements for replication in vitro. Virology (1982) 0.95
Comparison o;f vesicular stomatitis virus intracellular and virion ribonucleoproteins. J Virol (1980) 0.95
Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli. J Infect Dis (1988) 0.95
A cis-acting element within the hepatitis A virus 5'-non-coding region required for in vitro translation. Virus Res (1992) 0.94
Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br J Cancer (1996) 0.94
Investigation of the porcine MUC13 gene: isolation, expression, polymorphisms and strong association with susceptibility to enterotoxigenic Escherichia coli F4ab/ac. Anim Genet (2008) 0.94
The effect of phleomycin on poliovirus RNA replication. Virology (1970) 0.93
HeLa cell nucleolar RNA synthesis after poliovirus infection. Virology (1973) 0.93
Visual restoration and transplant connectivity in degenerate rats implanted with retinal progenitor sheets. Eur J Neurosci (2010) 0.92